Stringent patentability requirements present a challenge to obtaining broad-based antibody claims, so companies should develop a strategy based on multiple reinforcing layers of protection.
Jill Gorny Sloper
Advertisement
Jill Gorny Sloper is a partner at Nelson Mullins with a focus on patent law in the biotechnology, pharmaceutical, and life science fields, [email protected]
Articles by Jill Gorny Sloper
Advertisement
Latest Updated Articles
Patentability Considerations for Antibody-Related InventionsAugust 13th 2020
Advertisement
Advertisement